Valuation check: IQMDU's ROE is 2157193.89%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow2157193.89%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) currently reports a ROE of 2157193.89%. That is above the sector sector average of -5.68%. Use the charts on this page to explore Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s ROE history and peer comparisons.
Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s ROE of 2157193.89% is higher than the its sector sector average of -5.68%. That is roughly 37957712.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s current 2157193.89% should be judged against industry norms (sector average: -5.68%) and against IQMDU's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 2157193.89%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War), and consider following IQMDU for alerts when major investors trade the stock.